DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 076130
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
The generic ingredient in VOSPIRE ER is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
Summary for 076130
Tradename: | VOSPIRE ER |
Applicant: | Dava Pharms Inc |
Ingredient: | albuterol sulfate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Sep 26, 2002 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 8MG BASE | ||||
Approval Date: | Sep 26, 2002 | TE: | RLD: | No |
Complete Access Available with Subscription